Guard Therapeutics International AB (publ) (STO:GUARD)
Sweden · Delayed Price · Currency is SEK 1.695
+0.040 (2.42%)
Feb 11, 2026, 12:21 PM CET
STO:GUARD Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
12
Market Cap
33.38M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Alzinova AB | 26.12M |
| Nanologica AB | 22.65M |
| Scandinavian ChemoTech AB | 11.68M |
| ExpreS2ion Biotech Holding AB | 10.85M |
| AcouSort AB | 10.80M |
| OncoZenge AB | 2.78M |
| Aptahem AB | 2.47M |
| 2cureX AB | 1.98M |